Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL

被引：0
|
作者：
Cheung, MC [1 ]
Zhao, XQ [1 ]
Davis, JW [1 ]
Albers, JJ [1 ]
Chait, A [1 ]
Brown, BG [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
CIRCULATION | 1998年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2375
引用
收藏
页码：452 / 452
页数：1
相关论文
共 50 条
  • [1] Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL
    Cheung, MC
    Zhao, XQ
    Chait, A
    Albers, JJ
    Brown, BG
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) : 1320 - 1326
  • [2] Antioxidant supplements and simvastatin-niacin therapy - Response
    Cheung, MC
    Zhao, XQ
    Chait, A
    Albers, JJ
    Brown, BG
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) : 2099 - 2100
  • [3] Niacin Does Not Decrease Mortality in Patients with Coronary Artery Disease or Low HDL
    Shaughnessy, Allen F.
    AMERICAN FAMILY PHYSICIAN, 2017, 96 (02) : 129 - 129
  • [4] Simvastatin-niacin combination, but not antioxidant vitamins, increased SAA levels in the HDL atherosclerosis treatment study (HATS)
    O'Brien, KD
    Morse, J
    Frutkin, A
    Baas, AS
    Brown, BG
    CIRCULATION, 2002, 106 (19) : 74 - 75
  • [5] Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy
    Ballantyne, CM
    Herd, JA
    Ferlic, LL
    Dunn, JK
    Farmer, JA
    Jones, PH
    Schein, JR
    Gotto, AM
    CIRCULATION, 1999, 99 (06) : 736 - 743
  • [6] GENETICS OF LOW HDL IN TURKISH CORONARY ARTERY DISEASE PATIENTS
    Tokgozoglu, L.
    Alikasifoglu, M.
    Salanci, B. V.
    Kaya, B.
    Tulumen, E.
    Deniz, A.
    Aytemir, K.
    Kabakci, G.
    Oto, A.
    Sonmez, K.
    Ozkutlu, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 7 - 7
  • [7] Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
    Zhao, XQ
    Morse, JS
    Dowdy, AA
    Heise, N
    DeAngelis, D
    Frohlich, J
    Chait, A
    Albers, JJ
    Brown, BG
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (03): : 307 - 312
  • [8] Impact of simvastatin and niacin with or without antioxidants on plasma cholesterol absorption and synthesis markers in coronary artery disease patients with low HDL-cholesterol levels
    Matthan, N
    Giovanni, A
    Schaefer, E
    Brown, BG
    Lichtenstein, A
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A6 - A7
  • [9] Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL
    Matthan, NR
    Giovanni, A
    Schaefer, EJ
    Brown, BG
    Lichtenstein, AH
    JOURNAL OF LIPID RESEARCH, 2003, 44 (04) : 800 - 806
  • [10] Cholesteryl ester transfer protein polymorphisms influence HDL response to simvastatin and niacin therapy
    Grasso, AW
    Deeb, SS
    Morse, JS
    Frohlich, J
    Brunzell, JD
    Albers, JJ
    Brown, BG
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S161 - S162
12345